This resolution designates June 19, 2025, as "Juneteenth National Independence Day" to commemorate June 19, 1865 - the date Union troops in Galveston, Texas, delivered news of emancipation to enslaved people in the Southwest, months after the Civil War ended. It recognizes the historical significance of this date, when news of the end of slavery finally reached enslaved people in Texas. The resolution supports nationwide observance of Juneteenth to honor the emancipation of enslaved people and reflect on U.S. history. It does not create new laws or policies but formally acknowledges this date as part of the nation's heritage.
HRES 546 is a resolution encouraging Members of Congress to visit U.S. Immigration and Customs Enforcement (ICE) detention facilities in their states to observe conditions firsthand and fulfill oversight responsibilities. It references the 2024 Appropriations Act, which permits unannounced visits and prohibits facilities from altering conditions for such visits, ensuring transparency. The resolution cites concerns about recent cuts to oversight staff (including closed offices for detainee rights) and reports of overcrowding and inadequate medical care in detention centers. It aims to inform congressional efforts to address systemic issues in immigration detention without mandating visits.
This bill expands healthcare access for energy workers covered under the federal compensation program for occupational illnesses. It amends existing law to allow nurse practitioners and physician assistants (within their state-licensed scope and federal guidelines) to prescribe or order medical treatments, appliances, and supplies for eligible workers. The change directly affects energy workers receiving medical benefits under the Energy Employees Occupational Illness Compensation Program Act. It modifies the program’s authority to include these providers in prescribing decisions, aiming to streamline care without altering the program’s core eligibility or funding. The bill does not change who qualifies for benefits or the compensation amounts.
HR 4132, the Prescription Information Modernization Act of 2025, allows drug manufacturers to provide FDA-approved prescribing information for prescription drugs exclusively through electronic means, while requiring them to offer paper copies at no additional cost upon request by prescribers or dispensers. The bill directly affects drug manufacturers, doctors, pharmacists, and other healthcare professionals who rely on prescribing information. Key provisions include mandating that manufacturers give prescribers/dispensers the choice to continue receiving paper copies or request them as needed, and requiring the HHS Secretary to issue implementing regulations within one year to support this transition. The law takes effect two years after enactment or when final regulations are issued, whichever comes first.
This bill makes technical corrections to the Camp Lejeune Justice Act of 2022 to streamline claims for individuals harmed by water contamination at Camp Lejeune. It clarifies the evidence required (30+ days at the base plus a link between contaminants and health harm), specifies that cases must be handled in North Carolina courts (with limited transfer options), and sets attorney fee caps (20% before suit, 25% after). These changes directly affect veterans and civilians who lived at Camp Lejeune and filed claims under the 2022 law. The bill does not create new eligibility but aims to improve the legal process for existing cases.
SRES 296 is a Senate resolution condemning antisemitism and recent antisemitic attacks, specifically referencing the May 21, 2025, murders of Sarah Milgrim and Yaron Lischinsky at a Washington, DC, event and the June 1, 2025, Boulder, Colorado, Molotov cocktail attack. It cites data showing a record 9,354 antisemitic incidents in 2024 (a 63% rise in hate crimes since 2022) and notes Jewish Americans face disproportionate harm, including 68% of religious hate crimes despite being 2.4% of the U.S. population. The resolution does not create new laws but formally expresses the Senate’s condemnation, mourns the victims, and encourages society to combat antisemitism and support Jewish communities. It also recognizes the importance of existing federal resources, like the Nonprofit Security Grant Program, for community safety.
The Women’s Health Protection Act of 2025 (S 2150) prohibits state laws that impose unnecessary restrictions on abortion access before fetal viability. It directly affects patients seeking abortion care and health care providers (including clinics, hospitals, and medical professionals), banning requirements like mandatory in-person visits, location-based travel barriers, or restrictions on telemedicine that don’t apply to comparable medical procedures. The bill overrides conflicting state laws, requires courts to consider factors like cost and travel burden when evaluating restrictions, and establishes federal enforcement through lawsuits to stop violations. It focuses on ensuring access to abortion services without burdens that hinder care, while allowing post-viability abortions only when necessary to protect a patient’s life or health.
The Women's Health Protection Act of 2025 would protect access to abortion services across the United States by prohibiting states from imposing restrictions that are more burdensome than those on comparable medical procedures. The bill directly affects people seeking abortion care and health care providers by banning restrictions such as mandatory in-person visits, requirements for specific tests, limitations on telemedicine, and rules based on a patient's reason for seeking abortion. It prohibits state laws that single out abortion for unnecessary restrictions while allowing post-viability abortions when necessary to protect a patient's life or health. The bill preempts conflicting state laws and provides enforcement mechanisms through private lawsuits and actions by the Attorney General.
HR 4101, the Cancer Drug Parity Act of 2025, requires group health plans and insurance plans to provide equal cost-sharing (like deductibles and copays) for oral anticancer drugs as for intravenous or injected cancer drugs. This directly affects insured cancer patients prescribed oral medications, ensuring they face no higher out-of-pocket costs than for IV treatments when medically necessary. The law prohibits plans from changing benefits to increase costs for oral drugs or applying stricter limits on them compared to IV drugs. It takes effect for plan years starting January 1, 2026, and mandates a GAO study to assess the law’s impact on patient costs within two years of enactment.
The LEDGER Act (HR 4091) requires the Treasury Department to create a system tracking every government payment within 180 days of enactment. It mandates that all federal departments, agencies, and branches (executive, legislative, judicial) must report disbursements from every funding source, including how long funds remain available for spending. This system will detail each payment's origin, recipient, and timing across all government accounts. The bill directly affects all federal spending entities by standardizing expenditure tracking previously handled inconsistently.
This bill prohibits state officials from blocking abortion access for patients traveling from other states, including restricting providers who offer legal abortions in their state to out-of-state patients. It protects people traveling across state lines for legal abortions, those assisting such travel, and the interstate transport of FDA-approved abortion medication. Violations can be challenged by the Justice Department or affected individuals through civil lawsuits seeking injunctions and damages. The law applies broadly across all states, territories, and tribal nations, defining "abortion service" to include both medical procedures and related care.
This bill creates federal funding for community-based violence intervention programs in high-violence areas, targeting communities with 35+ homicides annually or 20+ homicides with rates double the national average. It establishes grants for community organizations to implement trauma-informed violence interruption strategies, hospital-based programs for injured patients, and job training for "opportunity youth" (16-25 year olds not in school or work). The legislation authorizes $300 million in 2026, increasing to $700 million annually through 2033, with requirements for evidence-based approaches that reduce violence without contributing to mass incarceration. It creates a National Community Violence Response Center to coordinate data collection, research, and best practices for these programs. The focus is on prevention through economic opportunity, trauma care, and community-driven interventions rather than traditional law enforcement approaches.
